(Press-News.org) Philadelphia, July 15, 2024 – Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children’s Hospital of Philadelphia (CHOP) demonstrated that mitochondrially-targeted antioxidants could reduce the effects of the virus while avoiding viral gene mutation resistance, a strategy that may be useful for treating other viruses. The preclinical findings were recently published in the journal Proceedings of the National Academy of Sciences.
Last year, a multi-institutional consortium of researchers found that the genes of the mitochondria, the energy producers of our cells, can be negatively impacted by the virus, leading to dysfunction in multiple organs beyond the lungs. SARS-CoV-2 proteins can bind to mitochondrial proteins in host cells as well as inhibit the expression of mitochondrial genes. While the virus that causes COVID-19 initially targets the lungs, eventually it can impact other organs, particularly the heart, and while the lungs may recover, mitochondrial function can remain suppressed in the heart and other visceral organs.
SARS-COV-2 infection disrupts mitochondrial oxidative phosphorylation (OXPHOS), the key process by which mitochondria generate cellular energy. This increases mitochondrial reactive oxygen species (mROS) which in turn activates hypoxia inducible factor-1alpha (HIF-1α). This causes the process to switch from burning carbohydrates and fats by OXPHOS for energy production to glycolysis which produces materials for viral production. The increased mROS also damages the mitochondrial DNA (mtDNA) which is released into the cytosol to activate the inflammatory systems, also affecting the organs.
“We suspected that we may be able to disrupt SARS-CoV-2’s ability to cause disease by reducing the amount of mROS, thus blocking the metabolic shift important for viral synthesis,” said the study’s first author Joseph W. Guarnieri, PhD, a postdoctoral fellow in the Wallace lab at the Center for Mitochondrial and Epigenomic Medicine (CMEM) at CHOP. “Since the key signal induced by the virus to drive the shift from energy production to viral substrate production is mROS, our next step was to determine if inhibiting mROS production could impair viral production and pathology.”
To test this hypothesis, researchers employed a mouse model expressing human ACE2 gene which permits SARS-CoV-2 cell infection. When treated with an antioxidant enzyme, mitochondrially targeted catalase or the mitochondrially-targeted catalytic antioxidant compound EUK8, the negative effects of viral infection such as weight loss, clinical severity and circulating levels of mtDNA, were all reduced, in association with increased lung OXPHOS, and reduced lung levels of HIF-1α, viral proteins and inflammatory cytokines.
“We believe that reducing mROS represents a superior strategy for mitigating the pathogenicity of SARS-CoV-2,” said senior study author Douglas C. Wallace, PhD, director of the CMEM at CHOP. “The virus is constantly mutating its ‘S’ protein gene to evade immunity induced by current anti-S vaccines. By modulating cmROS levels, we are rendering the host cell unfavorable for viral life cycle which the virus cannot change.”
This study was supported by Department of Defense W81XWH-21-1-0128 grant PR202887 and The Bill and Melinda Gates Foundation grant INV-04672. Additional grant support was provided by National Institutes of Health grants 1R01CA259635, 1R01AG078814 and R01NS114656 and Foerderer grant 00003469.
Guarnieri et al, “Mitochondrial Antioxidants Abate SARS-COV-2 Pathology in Mice.” Proc Natl Acad Sci USA. Online July 15, 2024. DOI: 10.1073/pnas.2321972121
About Children’s Hospital of Philadelphia:
A non-profit, charitable organization, Children’s Hospital of Philadelphia was founded in 1855 as the nation’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia. In addition, its unique family-centered care and public service programs have brought Children’s Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu.
END
Children’s Hospital of Philadelphia researchers develop antioxidant strategy to address mitochondrial dysfunction caused by SARS-CoV-2 virus
Preclinical data suggests a new strategy for treating complex cases of COVID-19 independent of mutations and variants
2024-07-15
ELSE PRESS RELEASES FROM THIS DATE:
How climate change is altering the Earth’s rotation
2024-07-15
Climate change is causing the ice masses in Greenland and Antarctica to melt. Water from the polar regions is flowing into the world’s oceans –and especially into the equatorial region. “This means that a shift in mass is taking place, and this is affecting the Earth’s rotation,” explains Benedikt Soja, Professor of Space Geodesy at the Department of Civil, Environmental and Geomatic Engineering at ETH Zurich.
“It’s like when a figure skater does a pirouette, first holding her arms close to her body and then stretching ...
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma
2024-07-15
“FDG-PET is generally considered as a useful metabolic evaluation tool, while it is also thought to have an emerging role for assessment of systemic therapy response.”
BUFFALO, NY- July 15, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.”
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm and affected ...
New concept explains how tiny particles navigate water layers – with implications for marine conservation
2024-07-15
A new UBC study published recently in Proceedings of the National Academy of Science (PNAS) has unveiled insights into how microscopic organisms such as marine plankton move through water with different density layers.
Researchers Gwynn Elfring and Vaseem Shaik found that density layers, created by variations in temperature or salinity, influence the swimming direction and speed of tiny particles navigating a liquid.
Pushers and pullers
“There are two different types of microscopic swimmers – ...
New research shows a frictionless state can be achieved at macroscale
2024-07-15
UTICA, NY – The president of SUNY Polytechnic Institute (SUNY Poly), Dr. Winston “Wole” Soboyejo, and postdoctoral researcher, Dr. Tabiri Kwayie Asumadu, have published a revolutionary new paper titled, "Robust Macroscale Superlubricity on Carbon-Coated Metallic Surfaces." This paper explores an innovative approach to reducing friction on metallic surfaces – a significant advancement that could have major real-world impacts.
The study shows that superlubricity – a state with virtually no friction that was once believed to only be achievable at nanoscale – can now be maintained at macroscale for extended time ...
A novel and unique neural signature for depression revealed
2024-07-15
HOUSTON - (July 15, 2024) - As parents, teachers and pet owners can attest, rewards play a huge role in shaping behaviors in humans and animals. Rewards – whether as edible treats, gifts, words of appreciation or praise, fame or monetary benefits – act as positive reinforcement for the associated behavior. While this correlation between reward and future choice has been used as a well-established paradigm in neuroscience research for well over a century, not much is known about the neural process underlying it, namely how the brain encodes, ...
Academic psychiatry urged to collaborate with behavioral telehealth companies
2024-07-15
Waltham — July 15, 2024 — The strengths of academic psychiatry departments and the fast-growing private telehealth sector are complementary, according to a Perspective article published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer. Justin A. Chen, MD, MPH, a psychiatrist at Weill Cornell Medicine in New York City, and colleagues reviewed literature on provision of outpatient mental health care in the United States. They concluded that academic psychiatry departments and telehealth companies could mutually benefit from strategic collaboration.
Academic medical centers struggle to ...
NASA’s Webb investigates eternal sunrises, sunsets on distant world
2024-07-15
Researchers using NASA’s James Webb Space Telescope have finally confirmed what models have previously predicted: An exoplanet has differences between its eternal morning and eternal evening atmosphere. WASP-39 b, a giant planet with a diameter 1.3 times greater than Jupiter, but similar mass to Saturn that orbits a star about 700 light-years away from Earth, is tidally locked to its parent star. This means it has a constant dayside and a constant nightside—one side of the planet is always exposed to its star, while the other is always shrouded in darkness.
Using Webb’s NIRSpec (Near-Infrared ...
Receptors make dairy cows a prime target for influenza, ISU team finds
2024-07-15
AMES, Iowa – As highly pathogenic avian influenza has spread in dairy herds across the U.S., the virus is being detected in raw milk. A new study by a broad team of researchers at Iowa State University’s College of Veterinary Medicine helps explain why.
Sialic acid, a sugar molecule found on the surface of some animal cells, acts as a receptor for influenza. Without sialic acid providing an entry point to attach, invade and infect, a flu virus is unlikely to find a potential host hospitable.
Before the recent HPAI outbreak ...
A new neural network makes decisions like a human would
2024-07-15
Humans make nearly 35,000 decisions every day, from whether it’s safe to cross the road to what to have for lunch. Every decision involves weighing the options, remembering similar past scenarios, and feeling reasonably confident about the right choice. What may seem like a snap decision actually comes from gathering evidence from the surrounding environment. And often the same person makes different decisions in the same scenarios at different times.
Neural networks do the opposite, making the same decisions each time. Now, Georgia Tech researchers in Associate Professor Dobromir Rahnev’s lab are ...
Wojtusiak to use artificial intelligence to help caregivers with social isolation
2024-07-15
Janusz Wojtusiak, Professor, Health Administration and Policy, College of Public Health, is set to receive funding for the project: “An Artificial Intelligence Solution to Social Isolation and Longlines of Caregivers of People with Dementia.”
Wojtusiak and his graduate student Ghaida Alsadah will lay the foundation for a large study aimed at utilizing AI methods to address social isolation and loneliness among people who care for those with Alzheimer’s Disease and those suffering from dementia.
Addressing ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Children’s Hospital of Philadelphia researchers develop antioxidant strategy to address mitochondrial dysfunction caused by SARS-CoV-2 virusPreclinical data suggests a new strategy for treating complex cases of COVID-19 independent of mutations and variants